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Abstract
Exosomes are nanometer-sized lipid vesicles released ubiquitously by cells, which have been shown to have a normal
physiological role, as well as influence the tumor microenvironment and aid metastasis. Recent studies highlight
the ability of exosomes to convey tumor-suppressive and oncogenic mRNAs, microRNAs, and proteins to a receiving
cell, subsequently activating downstream signaling pathways and influencing cellular phenotype. Here, we show that
radiation increases the abundance of exosomes released by glioblastoma cells and normal astrocytes. Exosomes
derived from irradiated cells enhanced the migration of recipient cells, and their molecular profiling revealed an
abundance of molecules related to signaling pathways important for cell migration. In particular, connective tissue
growth factor (CTGF) mRNA and insulin-like growth factor binding protein 2 (IGFBP2) protein levels were elevated,
and coculture of nonirradiated cells with exosomes isolated from irradiated cells increased CTGF protein expression
in the recipient cells. Additionally, these exosomes enhanced the activation of neurotrophic tyrosine kinase receptor
type 1 (TrkA), focal adhesion kinase, Paxillin, and proto-oncogene tyrosine-protein kinase Src (Src) in recipient cells,
molecules involved in cell migration. Collectively, our data suggest that radiation influences exosome abundance,
specifically alters their molecular composition, and on uptake, promotes a migratory phenotype.
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Introduction
The microenvironment plays an important role in tumor progression
and gene expression and influences response to therapeutic interven-
tions [1,2]. Extracellular vesicles—includingmicrovesicles and exosomes,
herein referred to as exosomes—are nanometer-sized membrane-derived
vesicles (averaging 100 nm in size) that contain various bioactive sub-
stances including RNA species [3], full-length protein receptors, ligands
[4,5], and DNA [6]. Exosomes can be found in various bodily fluids
and are secreted by cells in culture [7], and their composition is largely
dependent on their cell of origin [8]. Tumor exosomes are thought to
be an important mediator of intercellular signaling, fusing with recipi-
ent cells and transferring their bioactive molecules [3,7,8]. These events
enable communication between different tumor cells and between
tumor cells and the surrounding stromal cells. Specifically in cancer,
this mode of intercellular signaling has been shown to promote angio-
genesis [9,10], transfer oncogenes and tumor suppressor genes [5,11,12],
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enhance cell invasion [13], modulate the immune system [14], and help
establish a premetastatic niche [10,11]. Moreover, given their small size
and membrane protective coat, exosomes are capable of traveling
throughout the body to influence cell function at distant sites [11] and
are gaining attraction as novel clinical biomarkers [5,15,16].
Of the invasive cancers, glioblastoma multiforme (GBM) is con-
sidered one of the most aggressive and lethal. GBMs are capable of
influencing their microenvironment driving angiogenesis, evading
the immune system, and promoting degradation of the extracellular
matrix leading to local invasion [17]. Their local invasiveness results
in poorly defined margins for surgery, suboptimal treatment plan-
ning for radiation therapy, and their nearly universal recurrence in
patients, with a median survival of 15 months [18]. Although numer-
ous mechanisms contributing to the invasiveness of GBM have been
found, further studies identifying targetable mechanisms are needed.
Exosomes, given their small size and vast influence on cells within
the tumor and greater microenvironment, are an attractive target.
Although hypoxia has been shown to influence exosome composition
[19,20], there is, overall, a void of literature discussing how cancer
therapies influence exosome-mediated intercellular signaling. Here,
we provide evidence that radiation increases exosome release in a
variety of GBM cell lines and normal astrocytes. Exosomes released
from irradiated GBM cells enhanced the migration of recipient cells
in comparison to exosomes derived from nonirradiated cells, which
was abrogated by lysing exosomes before transferring them to cells.
These exosomes had a molecular profile containing an abundance of
molecules important for cell motility, in particular increased connec-
tive tissue growth factor (CTGF) mRNA and insulin-like growth factor
binding protein 2 (IGFBP2) protein. Moreover, when exosomes from
irradiated cells were taken up by nonirradiated cells, they increased the
expression of CTGF protein, likely a result of translation of the exosome
mRNA, as well as enhanced the activation of the signaling molecules in-
volved in cell migration, including increased activation of neurotrophic
tyrosine kinase receptor type 1 (TrkA), focal adhesion kinase (FAK),
Paxillin, and proto-oncogene tyrosine-protein kinase Src (Src).
Materials and Methods
Cell Lines
LN18, U87MG [American Type Culture Collection (ATCC),
Manassas, VA], and U251 (National Cancer Institute Frederick Tumor
Repository, Frederick, MD) GBM cell lines were grown in Dulbecco’s
modified Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA) with
10% FBS, used between passages 4 to 16, and revived every 2 to
3 months from frozen stocks made after receiving cell lines. Cell lines
were recently validated by Idexx Radil Laboratories (Columbia, MO).
U87MG cells expressing green fluorescent protein (GFP) were
graciously provided by Dr Jayne Stommel. GBAM1 and GBMJ1,
GBM stem-like cells, were established from patient resections, grown
as previously described [21], and used between passages 3 to 10. Astro-
cytes were purchased from ScienCell Research Laboratories (Carlsbad,
CA), grown in Astrocyte Medium with the recommended supplements
as per manufacturer’s instructions, and used between passages 3 to 9.
Human umbilical vein endothelial cells (HUVEC-CS) were obtained
from ATCC, grown on gelatin-coated dishes in DMEM containing
20% FBS, as per manufacturer’s instructions, and used up to passage
10. All cell cultures were maintained at 37°C and 5% CO2/95% air,
except stem cell cultures, which were maintained at 37°C and 5%
CO2/6% O2.
Radiation Treatment
Cells at 70% to 80% confluency were washed twice with phosphate-
buffered saline (PBS) and replenished with 5% exosome-depleted FBS
(dFBS; see below) in DMEM (LN18, U251, and U87MG) or stem cell
growth medium (GBAM1, GBMJ1, and astrocytes). Immediately
following, the flasks were treated with the indicated radiation dose
using an X-ray source (X-RAD 320; Precision X-Ray, North Branford,
CT; dose rate, 2.3 Gy/min) and incubated for 12 to 48 hours before
exosome isolation.
Exosome Isolation
Exosomes were isolated by ultracentrifugation, adapted from
Théry et al. [22]. Cell media were clarified of cells and cellular debris
by spinning media at 300g for 5 minutes, then at 3000g for 15 min-
utes at 4°C, before pelleting at 110,000g for 2 hours at 4°C. Exosomes
were washed in PBS and repelleted by an additional spinning at
110,000g for 2 hours. Exosomes were resuspended in PBS or lysed
in the appropriate buffer for additional analysis and stored at −20°C.
Uncentrifuged complete media (CM) and supernatant from the first
exosome pellet after ultracentrifugation were set aside for control
experiments. dFBS was generated by spinning FBS at 110,000g for
16 hours at 4°C. The supernatant of this spin was used as dFBS.
Nanoparticle Tracking Analysis
Exosomes were analyzed for size and concentration using a Nano-
Sight LM10 microscope and Nanoparticle Tracking Analysis soft-
ware version 2.2 (NanoSight, Amesbury, United Kingdom). See [23]
for details on application of the Nanoparticle Tracking Analysis (NTA)
instrument for exosome analysis. Exosome samples were diluted to
∼80 to 125 particles per frame for tracking, and >500 particles were
tracked. Particle tracking time, exposure level, and analysis settings
(detection threshold, auto; blur, 5 × 5;minimum size, 50 nm;minimum
track length, default) were kept identical for each group of experiments,
and each sample was analyzed twice to ensure accurate measurement.
Electron Microscopy
Scanning electron microscopy (EM) was carried out by the National
Cancer Institute–Frederick Core facility (Frederick, MD). Transmis-
sion EM was performed by placing 5 μl of exosomes suspended in
PBS on glow discharge copper grids and allowing them to settle for
1 minute before rinsing with distilled water. Exosomes were stained
with 1% uranyl acetate for 15 seconds before letting the grids dry.
Exosomes were examined under an FEI Tecnai12 transmission electron
microscope (FEI,Hillsboro,OR) operating at a beam energy of 120 keV.
Images were acquired using a Gatan 2k × 2k cooled charge-coupled
device (CCD) camera (Gatan, Warrendale, PA).
Fluorescent Labeling of Exosomes
Exosomes were labeled with the red-fluorescing, lipophilic dye
PKH26 according to the manufacturer’s recommendations (Sigma,
St Louis, MO) and Khatua et al. [24]. An equal volume of 5% dFBS/
DMEM was used to stop labeling before repelleting and washing twice
with 5% dFBS/DMEM to remove excess PKH26. Labeled exosomes
were resuspended in PBS and stored at −20°C.
5-Bromouridine 5´-Triphosphate Labeling of Exosome RNA
Cellswere grown in5%dFBSmedia containing100μM5-Bromouridine
5´-triphosphate (BrUTP, Sigma), following methods described by
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Ohtsu et al. [25] to label nascent RNA. After 48 hours, media were
collected; exosomes containing brominated mRNA were pelleted by
ultracentrifugation. The exosomes containing brominated mRNA
(25 μg/ml) were added in coculture with U87MG cells for 6 hours,
after which cells were washed twice with PBS and fixed with normal
buffered formalin, and a fluorescein isothiocyanate–conjugated anti-
bromodeoxyuridine antibody (Santa Cruz Biotechnology, Dallas, TX;
1:50 dilution) was used to detect brominated RNA. Images were
collected using a Leica upright fluorescent microscope (Leica,
Solms, Germany).
Exosome Transfer Experiments
In a method guided by Al-Nedawi et al. [4], 15,000 cells were
seeded on glass coverslips, allowed to adhere overnight, and washed
twicewith PBS, and then PKH26-labeled exosomes diluted 5 to 10 μg/ml
in 5% dFBS/DMEM were added. At the indicated time point, cover-
slips were removed, washed once with PBS, fixed with 10% normal
buffered formalin, washed twice in PBS, and mounted to slides with
mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI;
Vector Shield, Burlingame, CA). Images were captured using a Carl
Zeiss (Baltimore, MD) LSM 510 laser scanning confocal microscope.
For flow cytometry, 100,000 cells were seeded into 12-well plates,
allowed to adhere overnight, and then incubated with PKH26-labeled
exosomes diluted 5 to 10 μg/ml in 5% dFBS/DMEM from 30minutes
to 24 hours.Measurement of uptake was captured using a FACSCalibur
flow cytometer (BD Biosciences, Bedford, MA) and analyzed using
FlowJo Software version 7.6.5 (Ashland, OR).
In vitro Migration Assay
Transwell chambers (BD Biosciences) were used for in vitro assays
of cell migration according to the manufacturer’s recommendation
(pore size, 8.0 μm). Exosomes (isolated from culture media at 48 hours
after treatment with 4 Gy or no irradiation) were diluted in serum-free
DMEM in the lower chamber from 1 to 100 μg/ml. Cells were allowed
to migrate for 24 hours; then the upper chamber was scraped twice to
remove nonmigrated cells and stained with crystal violet, and the
number of migrated cells was counted. Ten 20× fields were counted
per condition using a Leica microscope. For pretreatment of cells
with exosomes, cells were plated onto 100-mm dishes, incubated with
25-μg/ml exosomes for 24 hours, and then washed and seeded in
serum-free DMEM in the upper chamber with no exosomes added
to the lower chamber. For inhibition of migration experiments, exo-
somes or dFBS were incubated with 0.2% Triton X-100 (Tx-100) in
PBS, at 37°C for 15 minutes before use.
Immunoblot analysis
Cells were seeded onto 60-mm dishes, allowed to attach overnight,
washed twice with serum-free DMEM, and serum starved for 16 hours
after which exosomes were added at a concentration of 25 μg/ml in
serum-free DMEM. At 24 hours, cells were lysed in radioimmunopre-
cipitation assay (RIPA) buffer (Sigma) containing phosphatase (Sigma)
and protease inhibitors (Roche, Indianapolis, IN). Protein concentra-
tion was quantified using a DC Protein Assay kit (Bio-Rad Laborato-
ries, Hercules, CA). Thirty micrograms of protein was resolved on 4%
to 20% Tris-Glycine gels and transferred to nitrocellulose membranes
(Bio-Rad Laboratories). Immunoblot analysis of exosome lysates was
done in the same fashion. Primary antibodies were given as fol-
lows: actin, CD9 (Millipore, Germany), CTGF, tumor susceptibility
gene 101 (tsg101; Santa Cruz Biotechnology), apoptosis-linked gene
2-interacting protein X (Alix), IGFBP2, phospho-/total TrkA, phospho-/
total FAK, phospho-/total Paxillin, and phospho-/total Src (Cell Signal-
ing Technology, Danvers, MA). Secondary HRP-conjugated anti-
bodies were purchased from Santa Cruz Biotechnology. Blots with
exosome lysates or phosphorylated targets were developed using Super-
Signal West Femto luminol substrate (Thermo Scientific, Rockfold, IL)
and with other probes using ECL Prime luminol reagent (GE Health-
care, Pittsburgh, PA). Actin was used as a loading control.
Antibody Array Analysis
Pelleted exosomes were lysed as above. Glass protein arrays (human
angiogenesis antibody array AAH-ANG-G1 and cytokine antibody
array G series AAH-CYT-G6/7/8; RayBiotech, Norcross, GA) were
used to detect protein levels in exosome samples. Assays were carried
out according to the manufacturer’s recommendations (15 μg of exo-
some lysate per subarray). Array values were standardized against the
positive control within each subarray. Samples were run as biologic
replicates, and a 1.33-fold change or greater was used as a cutoff
to explore significant targets (increased or decreased abundance),
comparing radiation-derived exosomes to those derived from non-
irradiated cells.
Microarray Analysis for mRNA and microRNA
To characterize exosome RNA composition, total RNA was
extracted from washed/pelleted exosomes using the mirVana miRNA
Isolation Kit (Invitrogen/Ambion) according to the manufacturer’s
recommendations. mRNA expression was assayed using cDNA
arrays as previously described [26]. MicroRNA (miRNA) expression
changes were analyzed using the FlashTag Biotin HSR RNA Labeling
Kits and GeneChip miRNA 2.0 Arrays, according to the manufac-
turer’s instructions (Affymetrix, Santa Clara, CA). R software was
used to process cDNA array data by subsetting on the basis of P value
of <.05 between conditions before further downstream analysis.
A ≥1.33-fold change was used as a cutoff to explore significant
increased/decreased targets comparing radiation-derived exosomes
to those derived from nonirradiated cells for mRNA changes. The
P value of <.05 was used as the only cutoff for the miRNA changes.
Real-Time Quantitative Polymerase Chain Reaction
Real-time quantitative polymerase chain reaction (PCR) was done
using QuantiTect Reverse Transcription and SYBR Green PCR kits
according to manufacturer’s specifications (Qiagen, Valencia, CA).
The following prevalidated primer sets were used: CTGF (Sigma)
and beta-actin (ACTB) (Quanta BioSciences, Gaithersburg, MD). Re-
actions were run in an Applied Biosystems (Foster City, CA) 7500 Real-
Time PCR thermal cycler, and the 2−ΔΔCt method was used to calculate
relative expression. ACTB was used as the endogenous control.
Ingenuity Pathway Analysis
Array data were analyzed using Ingenuity Pathway Analysis (IPA)
software (Ingenuity Systems, Redwood City, CA) and a 1.33-fold
cutoff for increased/decreased molecules to perform functional
classifications comparing radiation-derived exosomes to those derived
from nonirradiated cells. Top associated network functions and
molecular/cellular functions were explored. Analyses were performed
in the Spring 2012 build of IPA.
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Statistical Analysis
All experiments were performed a minimum of three times, unless
otherwise noted. Figures represent the average of independent replicates
with the SEM. Statistical tests were two sided for comparisons between
groups using a Student’s t test. Comparison of dose enhancement in
exosome abundance was analyzed using a one-way analysis of variance.
A P value of <.05 was considered significant. All analyses were com-
pleted using R statistical software and GraphPad Prism (GraphPad
Prism Inc, San Diego, CA).
Results
Confirmation of Exosome Isolation by Ultracentrifugation
The isolation of pure and intact exosomes was confirmed by scan-
ning and transmission EM. Scanning EM showed budding vesicle–
like structures on the surface of U87MG cells, which had a diameter
of ∼100 nm (Figure 1A). Transmission EM of U87MG exosomes
showed characteristic disk-like exosomes, also ∼100 nm in diameter
(Figure 1B). NTA measured exosomes with a mean size of 139.83 ±
29.03 nm (SEM), which was not significantly influenced by irradia-
tion (Figure W1A). Given the size distribution of the isolated exosomes
in this work, the exosome preparation is likely devoid of apoptotic
bodies that are larger [27], and irradiation of cells with 4 Gy does
not induce significant apoptosis after a single fraction at 48 hours post-
treatment [28,29]. To confirm that exosomes could be transferred to a
recipient cell, PKH26-labeled exosomes were incubated with U87MG
cells expressing GFP, and the labeled exosomes were visible within the
cell cytoplasm confirming uptake by the cell, as well as along the cell’s
surface (Figure 1C). Immunoblot analysis showed that U87MG exo-
somes had known exosome markers [30]—Alix, tsg101, and CD9
(Figure 1D). A Ponceau stain of the nitrocellulose membrane demon-
strated that exosomes contain a selective pool of proteins compared to
the cells from which they were derived (Figure W1B).
Radiation Increases Exosome Release from Glioma and
Nonglioma Cells
To examine the influence of radiation on exosome release, cells
were grown in dFBS media, and exosomes were isolated from culture
media 12 to 48 hours after irradiation. In irradiated LN18, U251,
and U87MG cell lines, the increase in exosome abundance in culture
media at 48 hours varied from 1.23- to 1.79-fold compared to the
release of exosomes from nonirradiated controls (Figure 2A). GBM
stem-like cells (GBAM1 and GBMJ1) showed increased release of
exosomes following irradiation, with GBAM1 having a larger increase
(2.6-fold; Figure 2A). We also observed an increase in exosomes
released by normal astrocytes following irradiation (1.71-fold; Figure 2A).
We further characterized exosome release in U87MG and for sub-
sequent molecular and functional studies. Irradiation of U87MG cells
with 2 to 8 Gy significantly increased exosome abundance in a dose-
dependent fashion at 24 hours (Figure 2B). Furthermore, the abun-
dance of exosomes released after irradiation with 4 Gy was time
dependent, with a significant increase in exosome abundance at
24 and 48 hours after irradiation and a nonsignificant increase at
12 hours (Figure 2C ).
Radiation-Derived Exosomes Are Taken Up by
Cells in Coculture
Next, we examined whether exosomes derived from irradiated cells
influenced their uptake by a recipient cell. Exosomes from non-
irradiated cells and irradiated cells (herein referred to as radiation-
derived exosomes) were cocultured with U87MG cells and shown
to be taken up as early as 30 minutes after their addition (Figure 3A).
This was quantified by incubating U87MG cells with exosomes at
the same concentration for various amounts of time and then analyzing
exosome uptake by cells using flow cytometry. This confirmed the
confocal observations that uptake of exosomes was time dependent
(Figure 3B). There was an overall increased uptake of radiation-derived
exosomes in recipient cells at 24 hours compared to that of exosomes
from nonirradiated cells (Figure 3C), which proved to be a significant
1.3-fold increase in uptake (Figure 3D). Additionally, U87MG exo-
somes were taken up by another glioma cell line (U251), as well as
normal human astrocytes and HUVECs (Figure W1C ), showing
that exosomes from one cell type could be taken up by cells of dif-
ferent origins.
Radiation-Derived Exosomes Enhance Cell Migration
We recently showed that conditioned media derived from irradi-
ated glioma cells promoted cell migration and invasion [31], and we
hypothesized that this effect may be mediated in part by exosome
transfer. We tested this with the following two related experiments:
1) by measuring U87MG cell migration when U87MG exosomes
were used as a chemoattractant and 2) by measuring migration of
U87MG cells that were incubated with U87MG exosomes 24 hours
Figure 1. Confirming isolation of exosomes by ultracentrifugation. (A) Scanning electron micrograph of U87MG cell surface with vesic-
ular protrusions (arrows; scale bar, 250 nm) and (B) transmission electron micrograph of purified U87MG exosomes (scale bar, 100 nm).
(C) U87MG-GFP cells with PKH26-labeled exosomes in the cytoplasm and on the cell surface (white arrows). (D) Immunoblot analysis
shows presence of exosome markers in U87MG exosomes and parent cell line.
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Figure 3. Radiation-derived exosomes are more readily taken up by recipient cells. (A) Confocal microscopic visualization of exosomes
within cells. Exosomes are stained red with PKH26, and nuclei are stained blue with DAPI. (B) Flow cytometric quantitation of exosome
uptake by cells after 1 to 24 hours in coculture. (C and D) Radiation-derived exosome uptake (4-Gy exosomes) in recipient cells at
24 hours compared with exosomes from nonirradiated cells (0-Gy exosomes) incubated for the same time; (D) is the averaged value +
SEM of three independent experiments, relative to the 0-Gy condition. *P = .03.
Figure 2. Cellular irradiation increases exosome release. (A) Exosome abundance was measured by NTA at 48 hours after 4-Gy treat-
ment of GBM cells (LN18, U251, and U87MG; n = 3), GBM stem-like cells (GBAM1 and GBMJ1; n = 2), and normal astrocytes (n = 3).
(B) U87MG exosomes isolated at 24 hours posttreatment with 2 to 8 Gy were measured by NTA (n = 3). (C) Measurement of exosomes
released by irradiated (4 Gy) and control cells from 12 to 48 hours after treatment, relative to 0-Gy 12-hour condition (n = 3). All graphs
represent averaged values relative to 0-Gy condition + SEM; values normalized to number of cells present at time of exosome isolation.
*P < .05; #P < .01.
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before setting up the assay (Figure 4A). In both experiments, exo-
somes promoted cell migration (Figure 4, B and C ); however,
radiation-derived exosomes enhanced this effect, particularly when
preincubating exosomes with cells before setting up the assay
(Figure 4C ). The chemotactic effect was influenced by exosome con-
centration (Figure 4D), and radiation-derived exosomes at concentra-
tions ≥25 μg/ml significantly enhanced cell migration compared
with exosomes from nonirradiated cells (Figure 4E ).
To confirm that these effects were indeed the result of the uptake
of intact exosomes and not chemical components included with
pelleted exosomes (FBS and other chemokines/cytokines), exosomes
were lysed with Tx-100 to disrupt vesicle membranes. Tx-100–lysed
PKH26-labeled exosomes were no longer taken up in recipient cells
(Figure 4F ), confirming adequate lysis, and no longer induced cell
migration (Figure 4G ); however, dFBS-Tx100 (using the same lysing
concentration of Tx-100) and dFBS alone had similar levels of
migration, showing that the reduced migration was not due to the
presence of Tx-100 in culture conditions. Thus, the uptake of intact
exosomes is required to mediate exosome-induced cell migration.
Control experiments using the CM and supernatant after pelleting
exosomes showed no significant differences between irradiated and
unirradiated conditions (Figure W1D), which is likely due to the
presence of dFBS in all conditions but is removed from exosomes
during purification.
Molecular Profiling Reveals Changes Unique to
Radiation-Derived Exosomes
Given that radiation-derived exosomes enhanced the migration of
U87MG cells in vitro compared to exosomes from nonirradiated cells,
we characterized molecular drivers contributing to this phenotype.
Figure 4. Radiation-derived exosomes enhance cell migration. (A) Schematic of cell migration experiments. (B–E and G) Exosome effect
on the migration of U87MG cells across transwell membranes when used as a chemoattractant (B, D, E, and G) or by preincubating
exosomes with cells before assay setup (C); n = 3. (D) Cell migration in response to increasing exosome concentrations, quantified in
E as the averaged values + SEM; n= 3. (F) Uptake of PKH26-labeled exosomes before and after Tx-100 lysis. (G) Influence of Tx-100–lysed
exosomes and Tx-100/dFBS on cell migration; n = 3. Values represent the averaged values + SEM of three independent experiments.
Radiation-derived exosomes, 4-Gy exosomes; exosomes from nonirradiated cells, 0-Gy exosomes. *P < .05.
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Exosomes released byU87MG cells were processed for either total RNA
(24 hours and 48 hours postirradiation) or protein extraction (48 hours
postirradiation). Two-way hierarchical clustering of cDNA microarray
data demonstrated that mRNA changes present in radiation-derived
exosomes isolated at 24 and 48 hours (post–cell treatment) were more
similar to each other compared with nonirradiated controls (Figure 5A).
Using a 1.33-fold change cutoff, there were 1308 mRNA changes at
24 hours and 209 mRNA changes at 48 hours in radiation-derived exo-
somes, with 45 commonly overexpressed and 26 commonly under-
expressed transcripts in radiation-derived exosomes at each time
point compared to nonirradiated controls (Figure 5B). The greater
number of mRNA changes at 24 hours compared with at 48 hours
may be due to the relatively greater number of exosomes released by
U87MG cells after irradiation at 24 hours (Figure 2B) compared to
the difference at 48 hours (Figure 2C ). As miRNAs contained in
exosomes have demonstrated a functional role on transfer to cells [4],
we examined whether cellular irradiation altered the miRNA pack-
aging in exosomes. In contrast to the abundant mRNA changes,
radiation-derived exosomes showed few changes in their miRNA
composition at both 24 and 48 hours following irradiation (Fig-
ure W2, A and B). Finally, protein microarrays sampling a total of
194 proteins showed 34 proteins with increased abundance and 7
with decreased abundance at 48 hours in radiation-derived exosomes
compared to exosomes derived from nonirradiated cells (Figure 5C ).
Overall, molecular profiling showed numerous changes in the contents
of radiation-derived exosomes compared to exosomes derived from
nonirradiated cells.
Molecular Changes in Radiation-Derived Exosomes Relate to
Cell Migration Pathways
IPA was used to categorize the molecular changes in radiation-
derived exosomes into functional networks. Exosomes isolated at
48 hours were used in all functional studies to have a sufficient con-
centration of exosomes for assays, and functional characterization was
conducted using molecular changes present at that time point. IPA
identified Cellular Movement as a top associated network function
with a score of 39, as well as the top molecular and cellular function
Figure 5. Radiation alters the molecular composition of exosomes. (A) Two-way hierarchical clustering representation of exosome
mRNA content. Values shown compare radiation-derived exosomes to those derived from nonirradiated cells at 24 and 48 hours, using
a cutoff P value of <.05. Up-regulation, red; down-regulation, blue. (B) Venn diagram of the number of significant transcript changes
with ≥1.33-fold increased/decreased expression in radiation-derived exosomes compared to exosomes from nonirradiated cells. (C)
Protein array analysis of differentially expressed proteins in radiation-derived exosomes compared to exosomes from nonirradiated cells.
Values represent those with a ≥1.33-fold increased/decreased expression cutoff comparing radiation-derived exosomes to exosomes
from nonirradiated cells (n = 2).
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with 21 molecules and a P-value range of .0049 to .00001 (Figure 6A).
The functional network for Cell Movement is shown in Figure 6B with
the data combined from both the mRNA and protein arrays, with red
indicating the upregulated molecules in radiation-derived exosomes.
From the pathway in Figure 6B, IGFBP2, PDGF-B, chemokine
(C-C motif) ligand 23 (CCL23), CCL25 (protein array), CTGF,
and Wiskott-Aldrich syndrome protein family member 3 (WASF3;
cDNA array) have been implicated in promoting cancer cell migra-
tion or invasion [32–37]. The miRNA array data were analyzed
separately and showed that the few transcripts that were decreased
targeted pathways involved in cell motility (Figure W2C ); no func-
tional classes were identified for the increased miRNA transcripts.
Thus, mRNA and protein array analyses showed similar phenotypic
differences in radiation-derived exosomes and further confirmed
our observations of their influence on cell migration.
Radiation-Derived Exosomes Enhance FAK Signaling in
Recipient Cells On Uptake
Given that radiation-derived exosomes enhanced cell migration
and cell movement was a top network on IPA analysis, we investigated
known pathways involved in cell migration that could be activated.
First, we confirmed a pair of molecules from the molecular profiling
that appeared as hubs in the IPA analysis (Figure 6B) and were up-
regulated in radiation-derived exosomes: CTGF from the cDNA
arrays and IGFBP2 from the protein arrays. Real-time quantitative
PCR confirmed that the CTGF transcript was increased two-fold in
radiation-derived exosomes compared with nonirradiated controls
(Figure 7A, left). There was no increase in cellular CTGF mRNA fol-
lowing irradiation (Figure 7A, right). Immunoblot analysis for CTGF
showed no difference in CTGF protein in radiation-derived exosomes
(Figure 7B, left), though an increase was seen in the exosome-secreting
cells following irradiation (Figure 7B, right). There was no change in
IGFBP2 mRNA by microarray; however, protein array identified an
increase in IGFBP2 protein in radiation-derived exosomes. Immuno-
blot analysis confirmed that IGFBP2 protein was increased in radiation-
derived exosomes (Figure 7C , left) and in the exosome-secreting cells
following irradiation (Figure 7C , right). These findings suggest that
the cellular packaging of exosome content in response to irradiation is
selectively altered at the mRNA and protein levels.
Next, we examined how exosomes altered signaling networks in
recipient cells on uptake. Immunoblot analysis of cellular lysates
24 hours after exosomes were added in coculture demonstrated that there
was an increase in CTGF protein in cells incubated with radiation-
derived exosomes (4-Gy exosomes) compared with exosomes from
nonirradiated cells (0-Gy exosomes) or those in serum-free medium
(DMEM; Figure 7D). We confirmed that RNA could be transferred
to recipient cells by labeling the RNA in exosomes using a brominated
nucleotide (BrUTP; see Materials and Methods section). Coculture of
these exosomes (BrUTP exosomes) with nonbrominated cells resulted
in the detection of brominated RNA species in the recipient cell
(Figure 7E , middle panel), in a distribution similar to PKH26-labeled
exosomes incubated with cells for the same amount of time (Figure 7E ,
right panel). This confirmed that RNA packaged into exosomes could
be transferred to a recipient cell. In particular, this suggests that the
increased abundance of CTGF mRNA in radiation-derived exosomes
can be effectively transferred to and translated by a receiving cell into a
functional protein with phenotypic modifications.
Of the many pathways involved in cell migration, the FAK signal-
ing cascade plays a role in several cellular processes in response to
extracellular stimuli and can be activated by CTGF [33]. Immunoblot
analysis revealed that there was activation of members involved in
FAK signaling, including TrkA, FAK, Paxillin, and Src by exosomes
alone (0-Gy exosomes); however, coculture with radiation-derived
exosomes (4-Gy exosomes) further enhanced activation of these sig-
naling molecules (Figure 7F ). Phosphorylated TrkA and total TrkA
levels were increased with exosomes in coculture, and to a greater
Figure 6. Molecular profile of radiation-derived exosomes relates to pathways involved in cell movement. IPA of top networks from
mRNA and protein targets with greater abundance in radiation-derived exosomes. (A) Upper table: Associated Network Functions, lower
table: Molecular and Cellular Functions. (B) Cell movement network is overlaid with values from protein (outlined in blue) and mRNA
(outlined in green) arrays using targets with increased abundance in radiation-derived exosomes (red-filled molecules).
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extent with radiation-derived exosomes, as were phosphorylation
levels of FAK, Paxillin, and Src with no change in total protein.
Discussion
Increasing evidence supports exosome transfer as an important mech-
anism of intercellular signaling in tumors. In particular, this mode of
communication has implications for tumor biology, whereby exo-
somes can transfer biologic factors that alter the phenotype of re-
cipient malignant or stromal cells [7]. Recent work shows that
various cellular insults cause tumor cells to increase the release of and
alter the molecular composition of tumor exosomes [19,20]. We spe-
cifically examine the effect of ionizing radiation on exosome release and
signaling and provide evidence that radiation-derived exosomes from
GBM cell lines enhance cell migration through a mechanism involving
an organized change in exosome mRNA and protein composition
(Figure W3).
Our results show that radiation increases exosome release and that
this phenomenon is both dose and time dependent. This confirms
previous studies reporting this phenomenon [38,39]; however, to
our knowledge, this is the first systematic study showing exosome
release kinetics using a direct method of exosome measurement by
NTA. Although one may argue that dFBS could result in some level
of apoptosis due to depletion of factors in the serum, all media growth
conditions were identical, and thus, any effect of the media on exo-
some production was equivalent across all experimental conditions.
A recent report noted that p53 status in cells was important for exo-
some genesis in response to irradiation [38]; however, the current
study found that glioma cell lines with mutated p53 (LN18 and
U251) appeared to have a greater relative increase in exosome release
following irradiation compared with U87, which has wild-type p53.
This may be due to the neural origin of the cells studied, whereas Yu
et al. [38] examined cell lines of epithelial origin. In addition to
studying exosome release, we show that exosomes secreted by a
Figure 7. Radiation-derived exosomes augment signaling pathways associated with cell motility. (A) CTGF gene expression levels in
U87MG exosomes and cells by quantitative reverse transcription–PCR. Data represent averaged values + SEM, n = 3; radiation-derived
exosomes/cells were compared to nonirradiated controls. *P = .0184. (B) CTGF and (C) IGFBP2 protein levels on immunoblot analysis
exosome and whole-cell lysates. (D) Immunoblot analysis of CTGF on lysates from cells incubated for 24 hours in serum-free DMEM or
in coculture with exosomes (radiation-derived, 4-Gy exosomes; nonirradiated controls, 0-Gy exosomes). (E) Transfer of BrUTP-labeled
mRNA in exosomes to recipient cells (BrUTP exosomes, middle panel). Distribution of PKH26-labeled exosomes incubated for the same
time for comparison (right panel). (F) Influence of radiation-derived exosomes and control exosomes on activation of signaling molecules
involved in cell migration after coculture with cells for 24 hours.
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given tumor line can be taken up by different cell types in vitro,
including normal astrocytes and endothelial cells. Thus, radiation-
mediated exosome release has the potential to affect cells in the
tumor microenvironment.
In this study, radiation-derived exosomes were found to enhance
cell migration and had a molecular profile containing a greater abun-
dance of mRNA and protein molecules associated with cell motility.
Of note, CTGF mRNA and IGFBP2 protein were specifically
increased in radiation-derived exosomes, both of which are in-
volved in the migration/invasion of different cancer types, including
GBM [32,33,40,41]. CTGF is involved in diverse cellular functions
including cell adhesion, migration, survival, and proliferation [40]. We
show here that cellular uptake of radiation-derived exosomes increases
CTGF protein levels, likely due to translation of transferred exosome
mRNA. Edwards et al. demonstrate that CTGF facilitates formation
and activation of a CTGF–integrin beta-1 (ITGB1)–TrkA complex,
which increases the invasiveness of GBM stem cells [33]. We pre-
viously showed that radiation-induced changes in the conditioned
media of GBM cells activate members of the FAK signaling cascade
and promote GBM cell migration and invasion [31]. FAK signal-
ing involves a diverse set of players involved in its activation and
downstream signaling [42]. Activated TrkA interacts with Src [43],
whereas Src can directly modulate FAK function and vice versa
[44,45]. In this study, radiation-derived exosomes enhanced TrkA
activation and increase the activation of the following members
in the FAK signaling cascade: FAK, Paxillin, and Src, well docu-
mented to be involved in cell migration signaling [42,46]. Simi-
larly, IGFBP2 can promote cell migration in various glioma models
[32,41,47], and serum protein levels are being investigated as a
biomarker for early glioma detection/characterization and predict-
ing prognosis [48,49]. Thus, the molecular changes present in
radiation-derived exosomes augment signaling involved in cell migra-
tion within the exosome-receiving cell. Other groups have shown that
RNA transfer through exosomes can have functional effects on
recipient cells [50], and the data here support their work. CTGF
signaling through FAK was examined in more detail in light of
our previous work, though it is unlikely to be the sole factor influ-
encing the observed phenotype. Signally changes by simple uptake of
lipid vesicles, regardless of their content, augment endosomal
trafficking and signaling and could explain some of the increased
transcriptional/translational activity in recipient cells. This, how-
ever, would be similar in both experimental conditions and not
explain the enhanced phenotype seen with radiation-derived exo-
somes. The effect observed is likely a combination of factors—
new transcription, translation, and transfer of proteins—that re-
sults in the increased migration, and multiple molecules are likely
involved. Given that the molecular changes in exosome composi-
tion following irradiation were extensive, these are avenues for
future work.
In summary, we show that radiation influences the production
of exosomes and this effect is dose and time dependent. Radiation-
derived exosomes are more readily taken up in coculture with cells
and have specific alterations in their molecular composition that
enhance cell migration, at least in part due to enhanced activation
of TrkA and FAK signaling. Our study sheds light on the influ-
ence that therapeutic radiation may have in intercellular signaling
through exosomes, and strategies targeting exosomes [51,52] may
provide a novel therapeutic approach to counter exosome influ-
ence on tumor progression.
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Figure W1. Characteristics of exosomes derived from irradiated cells. (A) Size distribution of exosomes as measured by NTA. Averaged
values + SEM (n = 2). (B) Ponceau stain of nitrocellulose membrane containing 30 μg of total U87MG cell and exosome lysates
separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis. (C) Confocal microscopic visualization of U87MG exosome
uptake in various GBM cells (U87MG and U251), as well as normal human astrocytes and HUVECs. Exosomes are stained red with
PKH26, and nuclei are stained blue with DAPI. (D) Example of U87 cell migration experiment with exosomes, CM, or supernatant after
exosome pelleting from irradiated or unirradiated conditions shows only significant changes in exosome-specific experiments. Each
point represents an independently counted field.
Figure W2. miRNA profile of exosomes from irradiated and nonirradiated cells. (A) Two-way hierarchical clustering representation of
changes in exosome miRNA at 48 hours. Values represent a subset of the data using a P value of <.05 comparing radiation-derived
exosomes to those from nonirradiated cells at 48 hours. Up-regulation, red; down-regulation, blue. (B) Venn diagram representation of
the number of miRNA changes seen in exosomes at 24 and 48 hours following irradiation. (C) IPA of top networks. The miRNA targets
that were decreased in exosomes at 48 hours associated with cell movement as one of the top five molecular/cellular functions. No
network associations were generated by IPA when the few upregulated miRNA transcripts were used as the input data set.
Figure W3. Model of radiation’s influence on exosome release and signaling in gliomas. The influence of radiation on exosome release
and signaling after uptake in recipient cells is depicted.
